UroGen Pharma URGN
NASDAQ URGN
$40.63 +0.18 (+0.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Total Non-Current Liabilities (2019 - 2026)

Updated

UroGen Pharma (URGN) recorded Total Non-Current Liabilities of $381.08 million in Q2 2026, up 27.8% from $298.3 million a year earlier and up 1.9% from the prior quarter.

Analysis

UroGen Pharma (URGN) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, UroGen Pharma reported Total Non-Current Liabilities of $302.03 million, up 3.9% from FY2024.

  • Annual Total Non-Current Liabilities has increased for five straight years, with a five-year compound annual growth rate of 67.5% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $290.72 million in FY2024 (+21.0%), $240.33 million in FY2023 (+8.3%), $221.96 million in FY2022 (+104.6%) and $108.49 million in FY2021 (+373.1%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q1 2019.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 19 consecutive quarters, with growth averaging 18.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Total Non-Current Liabilities ranged from 3.9% (Q4 2025) to 888.4% (Q1 2022).
  • Per Business Quant, the preceding three quarters came in at $374.04 million (Q1 2026), $302.03 million (Q4 2025) and $296.66 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 UroGen Pharma 1.99 Bn 1.49 Bn 65.88 Mn 381.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381.08 Mn
Mar 31, 2026 374.04 Mn
Dec 31, 2025 302.03 Mn
Sep 30, 2025 296.66 Mn
Jun 30, 2025 298.30 Mn
Mar 31, 2025 290.29 Mn
Dec 31, 2024 290.72 Mn
Sep 30, 2024 273.23 Mn
Jun 30, 2024 248.34 Mn
Mar 31, 2024 237.51 Mn
Dec 31, 2023 240.33 Mn
Sep 30, 2023 232.61 Mn
Jun 30, 2023 230.78 Mn
Mar 31, 2023 226.49 Mn
Dec 31, 2022 221.96 Mn
Sep 30, 2022 188.92 Mn
Jun 30, 2022 184.21 Mn
Mar 31, 2022 179.95 Mn
Dec 31, 2021 108.49 Mn
Sep 30, 2021 100.35 Mn
API Access

UroGen Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=URGN&period=max&api_key=YOUR_API_KEY